Fender’s EVP of Product Justin Norvell explains what convinced Fender to change its mindset on where its guitars are built – ...

Corcept Therapeutics (CORT) shares soared 13.6% in the last trading session to close at $69.90. The move was backed by solid volume with far more shares changing hands than in a normal session.

Debuted by Martin Guitars at the National Association of Music Merchants’ annual trade show on Wednesday, Jan. 22, the bluegrass icon’s collaboration with the esteemed acoustic manufacturers ...

In this article, we are going to take a look at where Corcept Therapeutics Incorporated (NASDAQ:CORT) stands against the other hot stocks. While the stock market in the United States remained ...

So you’ve finally decided to take the plunge and start learning guitar, or maybe you’re buying for someone who wants to? Whatever it is, to prepare for a lifelong journey of creative fulfillment, ...

Lloyd Baggs has come full circle back to guitar design as a bespoke platform for his latest pickup system – the result could change expectations for stage acoustics ...